APA (7th ed.) Citation

Keilholz, U., & Schadendorf, D. (2016). Dacarbazine, Cisplatin, and Interferon-alfa-2b with or without Interleukin-2 in metastatic melanoma: A randomized phase III trial (18951) of the European Organisation for Research and Treatment of Cancer Melanoma Group. Journal of clinical oncology, 23(27), . https://doi.org/10.1200/JCO.2005.03.202

Chicago Style (17th ed.) Citation

Keilholz, Ulrich, and Dirk Schadendorf. "Dacarbazine, Cisplatin, and Interferon-alfa-2b with or Without Interleukin-2 in Metastatic Melanoma: A Randomized Phase III Trial (18951) of the European Organisation for Research and Treatment of Cancer Melanoma Group." Journal of Clinical Oncology 23, no. 27 (2016). https://doi.org/10.1200/JCO.2005.03.202.

MLA (9th ed.) Citation

Keilholz, Ulrich, and Dirk Schadendorf. "Dacarbazine, Cisplatin, and Interferon-alfa-2b with or Without Interleukin-2 in Metastatic Melanoma: A Randomized Phase III Trial (18951) of the European Organisation for Research and Treatment of Cancer Melanoma Group." Journal of Clinical Oncology, vol. 23, no. 27, 2016, https://doi.org/10.1200/JCO.2005.03.202.